Written Question · S4W-30106 · Session 4
What discussions it has had with NHS boards in relation to alerting patients who have had a mesh procedure to its concerns.
The question
To ask the Scottish Government what discussions it has had with NHS boards in relation to alerting patients who have had a mesh procedure to its concerns.
The answer
The Scottish Government has taken advice from a number of professionals, including the Chief Medical Officer’s medical staff, on the most effective way to communicate and support women who are experiencing complications following a mesh implant procedure.
Taking account of advice, the Scottish Government considers the most effective way to help any woman experiencing complications as a consequence of mesh surgery is to develop a pathway of care designed specifically for this purpose. This is a priority for the expert group, established to take forward the recommendations contained in the independent review’s interim report.
The expert group is considering improved sources of information. These are likely to include an e-learning package for healthcare professions, which may particularly benefit GPs, the first point of contact for most women.
A poster and letter advertising the mesh helpline and outlining reportable adverse events has been circulated to all health boards as well as primary care leads. The expert group is also exploring ways of improving the helpline and other support for women experiencing complications.
Taking account of advice, the Scottish Government considers the most effective way to help any woman experiencing complications as a consequence of mesh surgery is to develop a pathway of care designed specifically for this purpose. This is a priority for the expert group, established to take forward the recommendations contained in the independent review’s interim report.
The expert group is considering improved sources of information. These are likely to include an e-learning package for healthcare professions, which may particularly benefit GPs, the first point of contact for most women.
A poster and letter advertising the mesh helpline and outlining reportable adverse events has been circulated to all health boards as well as primary care leads. The expert group is also exploring ways of improving the helpline and other support for women experiencing complications.
In the Official Report
No contribution in the Official Report cites S4W-30106 by reference.